| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/13/2011 | US20110010805 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
| 01/13/2011 | US20110010803 Polypeptides, Such As Lipases, Capable Of Altering The Seed Storage Content In Transgenic Plants |
| 01/13/2011 | US20110010800 Plants with increased yield |
| 01/13/2011 | US20110010781 Method of Producing a Mouse Suitable for Engraftment, Differentiation and Proliferation of Heterologous Cells, Mouse Produced by This Method and Use of the Mouse |
| 01/13/2011 | US20110009603 Method and composition for crystallizing G protein-coupled receptors |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009598 Method of producing cell extract for cell-free protein synthesis |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110009291 Methods and compositions for increasing membrane permeability |
| 01/13/2011 | US20110009280 Multi-chain eukaryotic display vectors and uses thereof |
| 01/13/2011 | US20110008843 Process for obtaining botulinum neurotoxin |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008841 Polynucleotides encoding il-17 receptor a antigen binding proteins |
| 01/13/2011 | US20110008840 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 01/13/2011 | US20110008839 Expression Vectors Comprising the MCMV IE2 Promoter |
| 01/13/2011 | US20110008838 Chimeric varicella zoster virus virus-like particles |
| 01/13/2011 | US20110008837 Modifying glycoprotein production in plans |
| 01/13/2011 | US20110008836 Method for producing alpha-santalene |
| 01/13/2011 | US20110008835 System for the heterologous expression of a viral protein in a ciliate host cell |
| 01/13/2011 | US20110008834 Polynucleotides encoding antibodies directed against amyloid-beta peptide |
| 01/13/2011 | US20110008833 Protein production in plant cells and associated methods and compositions |
| 01/13/2011 | US20110008832 Methods for stably retaining foreign genes in cells |
| 01/13/2011 | US20110008831 Scalable fermentation process |
| 01/13/2011 | US20110008830 Process for producing bio-gel and a bio-gel |
| 01/13/2011 | US20110008829 Use of Synthetic Scaffolds for the Production of Biosynthetic Pathway Products |
| 01/13/2011 | US20110008828 Methods of incorporating amino acid analogs into proteins |
| 01/13/2011 | US20110008827 Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization |
| 01/13/2011 | US20110008812 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 01/13/2011 | US20110008782 Site-specific incorporation of redox active amino acids into proteins |
| 01/13/2011 | US20110008523 Genetic sequences having methyltransferase activity and uses therefor |
| 01/13/2011 | US20110008377 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 01/13/2011 | US20110008364 Antibodies to tgf-beta |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008360 Human antibodies against rabies and uses thereof |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008355 Anti-flt3 antibodies |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008345 Antigen-binding constructs |
| 01/13/2011 | US20110008344 Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008339 Monoclonal antibody and use thereof |
| 01/13/2011 | US20110008330 Compositions and methods of tolerizing a primate to an antigen |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008321 Vectors, Host Cells, and Methods of Production and Uses |
| 01/13/2011 | US20110008309 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 01/13/2011 | US20110008301 Human adipose derived insulin making mesenchymal stem cells for treating diabetes mellitus |
| 01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/13/2011 | US20110008249 Proteins with high immunoreactivity and method for their production |
| 01/13/2011 | CA2767600A1 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions |
| 01/13/2011 | CA2767225A1 Compositions and methods for enhancing production of a biological product |
| 01/13/2011 | CA2766405A1 Engineered fc regions for site-specific conjugation |
| 01/13/2011 | CA2766166A1 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering |
| 01/12/2011 | EP2272961A1 Process for producing recombinant albumin with reduced mannosylation |
| 01/12/2011 | EP2272960A1 Human protein NELL2 gene |
| 01/12/2011 | EP2272959A1 BMP-11 compositions |
| 01/12/2011 | EP2272946A2 Minicell compositions and methods |
| 01/12/2011 | EP2272872A1 Monoclonal antibody specifically recognizing human interferon alpha subtype alpha-8 and mutant protein thereof |
| 01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
| 01/12/2011 | EP2272861A1 Polyepitope carrier protein |
| 01/12/2011 | EP2272859A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 01/12/2011 | EP2272533A1 Soluble FcyR fusion proteins and methods of use thereof |
| 01/12/2011 | EP2271759A1 Host cells and methods of producing disulfide bond containing proteins |
| 01/12/2011 | EP2271665A1 Highly bridged peptides from actinomadura namibiensis |
| 01/12/2011 | EP1865058B1 Anti-cd-20 monoclonal antibody |
| 01/12/2011 | EP1453858B1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
| 01/12/2011 | EP1317186B1 Improved bioactive whey protein hydrolysate |
| 01/12/2011 | EP1302541B1 Method for recognizing bacterial DNA |
| 01/12/2011 | EP1105479B1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 01/12/2011 | EP0821736B1 Bacteriocins |
| 01/12/2011 | CN1982336B Human pancreas glucagon sample peptide-1-derivative, its production and use |
| 01/12/2011 | CN1714147B Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 01/12/2011 | CN101946003A Anti-adam-15 antibodies and utilization of the same |
| 01/12/2011 | CN101945894A Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| 01/12/2011 | CN101942496A Method for preparing virus analogs of nervous necrosis viruses |
| 01/12/2011 | CN101942470A Methods for preventing gluconoylation of proteins |
| 01/12/2011 | CN101942023A Human epidermic growth factor ferritin heavy chain subunit fusion protein, constructing method and use thereof |
| 01/12/2011 | CN101942022A Anti-human epidermal growth factor receptor single-chain antibody-ferritin heavy chain subunit protein and construction method and application thereof |
| 01/12/2011 | CN101940189A Transgenic trasnchromosomal rodents for making human antibodies |
| 01/12/2011 | CN101565690B Enrofloxacin monoclonal antibody and application |
| 01/12/2011 | CN101029081B Recombinant incretin peptide and method for constructing and culturing producing strain |
| 01/11/2011 | US7868227 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
| 01/11/2011 | US7868168 High viscosity xanthan polymer preparations |
| 01/11/2011 | US7868155 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/11/2011 | US7868151 Recombinant human interferon-like proteins |
| 01/11/2011 | US7868150 Nucleic acids encoding T2R taste receptors |
| 01/11/2011 | US7868137 Search for cancer markers by a novel screening method |
| 01/11/2011 | US7868136 Search for cancer markers by a screening method |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | US7867748 dehydrated immobilized enzyme catalyst having improved specific activity upon rehydration; used as catalyst for the conversion of glycolonitrile to glycolic acid |
| 01/11/2011 | US7867744 Glucanase for biodegradation of plant biomass to be used in ethanol fermentation |
| 01/11/2011 | US7867743 phytases derived from Citrobacter braakii, belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed |
| 01/11/2011 | US7867741 Purified enzyme having an activity in the MTBE degradation path; novel bacterial strain Mycobacterium austroafricanum; bioremediation of water contamination |
| 01/11/2011 | US7867735 L-glutamic acid producing bacterium and a method for production of L-glutamic acid |
| 01/11/2011 | US7867734 Monoclonal antibody for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy |
| 01/11/2011 | US7867733 Method for producing factor G derived from horseshoe crab |
| 01/11/2011 | US7867732 high-mannose-type sugar chain bound to a chicken antibody; BML-17; useful in medical, pharmaceutical industries, and industries relating to test agents |
| 01/11/2011 | US7867731 HX2004-6 polypeptide expressed in cancerous cells |
| 01/11/2011 | US7867730 production system for a recombinant glycoprotein having therapeutic value in humans using a methylotrophic, thermotolerant yeast; host system for mass production of recombinant hepatitis vaccines |
| 01/11/2011 | US7867502 Genetic engineered polypeptides; useful candidates in a vaccine against tuberculosis (TB) or diagnostic preparation for TB; vaccine; inhibit mycobacterial virulence |
| 01/11/2011 | US7867501 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |